Valuation : QHSLab, Inc.

Market Cap 4.81M 4.14M 3.92M 3.56M 6.67M 460M 6.71M 46.61M 17.92M 234M 18.07M 17.67M 739M P/E 2024
-8.27x
P/E 2025 30.3x
Enterprise Value 4.47M 3.85M 3.64M 3.3M 6.2M 427M 6.23M 43.28M 16.64M 217M 16.78M 16.41M 686M EV / Sales 2024
1.97x
EV / Sales 2025 2.41x
Free-Float
66.08%
Yield 2024 *
-
Yield 2025 -
1 day-24.24%
1 week+42.86%
Current month+42.05%
1 month+42.86%
3 months+100.00%
6 months-24.47%
Current year-17.48%
1 week 0.32
Extreme 0.32
0.5
1 month 0.3
Extreme 0.3
0.5
Current year 0.23
Extreme 0.233
1.14
1 year 0.08
Extreme 0.08
1.14
3 years 0.02
Extreme 0.0155
1.14
5 years 0.02
Extreme 0.0155
1.14
10 years 0
Extreme 0.005
1.14
Manager TitleAgeSince
Chief Executive Officer 49 2016-06-27
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2024-05-01
Director TitleAgeSince
Chairman 49 2016-06-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/26/26 Héritage -2,226,280 14.8095%
12/31/25 Others

Chief Executive Officer

2,644,424 100.0000%
12/31/25 Conversion

Chief Executive Officer

213,075 1.8887%
Change 5-day change 1-year change 3-year change Capi.($)
-24.24%+42.86%+212.50%+614.29% 4.81M
+1.10%-0.65%+27.19%+19.36% 225B
-0.19%-3.62%+5.31%-20.72% 141B
+2.41%+0.67%-17.91%+21.95% 130B
-0.28%-10.08%-58.15%-19.21% 62.29B
-0.49%-1.97%-19.72%-14.57% 49.39B
-2.77%-6.15%+8.77%+15.31% 48.63B
+2.66%-2.61%+19.22%+29.53% 41.42B
+1.67%-0.25%+38.24%+52.80% 40.12B
-0.60%-4.41%-19.20%+49.15% 31.23B
Average -2.07%-2.91%+19.62%+74.79% 76.97B
Weighted average by Cap. +0.67%-2.40%+2.73%+10.42%

Financials

2024 2025
Net sales 2.13M 1.84M 1.74M 1.58M 2.96M 204M 2.97M 20.66M 7.94M 104M 8.01M 7.83M 327M 2.69M 2.32M 2.2M 1.99M 3.73M 257M 3.75M 26.08M 10.03M 131M 10.11M 9.89M 413M
Net income -259K -223K -211K -192K -360K -24.77M -361K -2.51M -966K -12.6M -974K -952K -39.81M 457K 394K 373K 338K 635K 43.7M 638K 4.43M 1.7M 22.23M 1.72M 1.68M 70.25M
Net Debt 1.58M 1.36M 1.29M 1.17M 2.19M 151M 2.2M 15.3M 5.88M 76.73M 5.93M 5.8M 242M -343K -296K -280K -254K -476K -32.8M -479K -3.33M -1.28M -16.68M -1.29M -1.26M -52.72M
Logo QHSLab, Inc.
QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.
Employees
12
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. USAQ Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!